CAPRICOR THERAPEUTICS, INC. (CAPR) Net margin 2016–2024
CAPRICOR THERAPEUTICS, INC. (CAPR) net profit margin by fiscal year — reported net income divided by reported revenue.
-181.7%FY2024 · since FY2016: -470.3% → -181.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -181.7% | -93.2 pp |
| FY2023 | -88.5% | +1048.8 pp |
| FY2022 | -1137.4% | +7038.5 pp |
| FY2021 | -8175.9% | -3773.9 pp |
| FY2020 | -4401.9% | -3641.6 pp |
| FY2019 | -760.4% | +148.5 pp |
| FY2018 | -908.9% | -1000.1 pp |
| FY2017 | 91.2% | +561.5 pp |
| FY2016 | -470.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CAPR financial trends
CAPR RevenueCAPR Net incomeCAPR Gross profitCAPR Gross marginCAPR Operating incomeCAPR Operating marginCAPR Operating cash flowCAPR Free cash flowCAPR Capital expendituresCAPR Return on equityCAPR Stock buybacksCAPR Dividends paidCAPR Total assetsCAPR Total liabilitiesCAPR Shareholders’ equityCAPR overview →